CoChat

How Much Do Persons with Alzheimer's Disease Cost Medicare?

Taylor, Donald H., Sloan, Frank A. · 2000 · Journal of the American Geriatrics Society
Cited by 99

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

BACKGROUND : Medicare claims are increasingly being used to identify persons with chronic diseases such as Alzheimer's disease (AD) for the purpose of determining the cost to Medicare of caring for such persons. Past work has been limited by the use of only 1 or 2 years of claims data to identify cases, leading to worries that this might lead to an undercount of prevalent cases and bias cost findings. OBJECTIVES : To analyze the average total cost to the Medicare program in 1994 of persons with a claims‐based diagnosis of AD, using a 12‐year period of claims history to identify prevalent cases, and to investigate the effect on cost of time since diagnosis. DESIGN : A cross‐sectional design with a 12‐year retrospective period to identify persons with AD. SETTING : Medical care practices, hospitals, and other providers of services to Medicare beneficiaries in the US in 1994. SUBJECTS : Respondents to the screener (n = 10,858) and community (5429) and institutional (n = 1341) questionnaire of the 1994 National Long Term Care Survey, with and without a claims‐based diagnosis of AD. MEASUREMENTS : Average total cost to Medicare in 1994, measured as the actual amount Medicare paid for inpatient, outpatient, home health, skilled nursing facility, hospice, and Part B services, including payments to physicians, and other items such as durable medical equipment. We also measured disability in a variety of ways, including cognition, activity limitations, and residence in a nursing home. RESULTS : The average total cost to Medicare of persons with a claims‐based diagnosis of AD was $6021 versus $2310 ( P < .001) for persons without a diagnosis. When adjusting for patient characteristics, the ratio of cost between persons with AD and those without was reduced to about 1.6 to 1. Time since diagnosis was an important predictor of average total cost in 1994, with each additional year since diagnosis resulting in a $248 (P = .04) decrease in total cost (about 10% of the total sample mean cost of $2426). There was mixed evidence that persons with a diagnosis of AD incurred less cost than otherwise similarly disabled Medicare beneficiaries. CONCLUSIONS : Time since diagnosis with AD is an important predictor of cost and one that should be explicitly included in any rate‐setting formula. Expanding the period used to identify cases resulted in an increase in the unadjusted ratio of cost of a Medicare beneficiary with AD relative to one without primarily because our control group costs are lower compared with those of past work. J Am Geriatr Soc 48:639–646, 2000 .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1532-5415.2000.tb04721.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 99

Metadata

Authors
Taylor, D. H., & Sloan, F. A.
Venue
Journal of the American Geriatrics Society
Publisher
Wiley
Published
2000-06
Volume
48
Issue
6
Pages
639-646
ISSN
  • 0002-8614 (ISSN-L)
  • 1532-5415
OpenAlex
W2001861525
Cited by
99
References
3
FWCI
5.79
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: How Much Do Persons with Alzheimer's Disease Cost Medicare? https://app.cochat.ai/papers/10.1111/j.1532-5415.2000.tb04721.x
The paper
Taylor, D. H., & Sloan, F. A. (2000). How Much Do Persons with Alzheimer's Disease Cost Medicare? Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2000.tb04721.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.